Augustine Therapeutics raises €77.7 million in Series A funding
LEUVEN: Augustine Therapeutics NV announced the successful completion of its €77.7 million ($84.8 million) Series A funding round. Co-led by Novo Holdings and Jeito Capital, the financing also included investments from Asabys Partners, Eli Lilly, AdBio Partners, V-Bio Ventures, and others….